AbbVie
ABBV
ABBV
3,305 hedge funds and large institutions have $198B invested in AbbVie in 2023 Q4 according to their latest regulatory filings, with 362 funds opening new positions, 1,168 increasing their positions, 1,417 reducing their positions, and 98 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.65% more ownership
Funds ownership: 69.58% → 72.23% (+2.6%)
10% less funds holding in top 10
Funds holding in top 10: 222 → 200 (-22)
18% less repeat investments, than reductions
Existing positions increased: 1,168 | Existing positions reduced: 1,417
Holders
3,305
Holding in Top 10
200
Calls
$4.51B
Puts
$2.44B
Top Buyers
| 1 | +$5.57B | |
| 2 | +$801M | |
| 3 | +$394M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$370M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$367M |
Top Sellers
| 1 | -$521M | |
| 2 | -$497M | |
| 3 | -$402M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$259M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$218M |